- Round also saw participation from SucSeed Indovation and SINE IIT-B
- Endimension is a healthcare AI startup that provides accurate and early diagnosis of diseases from radiology scans.
- Funds raised to be utilized for research and development, team expansion, software development and sales enhancement
- Endimension’s platform has conducted over 1 million patient scans and is present in 400 hospitals and diagnostic centers spanning various regions, thereby improving their accessibility
- So far, Inflection Point Ventures has invested over INR 700 Cr across 250+ startups
Endimension Technology, a healthcare AI startup has raised INR 6 Crore in Pre-Series A round led by Inflection Point Ventures. Other investors in this round include Sucseed Indovation, SINE IIT Bombay and individual angel investors. Endimension Technology, incubated at IIT Bombay, is driven by the vision to harness AI technology in radiology, ensuring early and precise diagnosis for patients globally.
The funds will be utilized to fuel AI research and development, team expansion, software enhancement. These strategic investments aim to bolster their market position, accelerate growth, and establish Endimension as an industry leader.
L-R_Bharadwaj Kss (Founder & CEO) – Apparao Mlv (CoFounder & COO) – Karthik K (CTO), Endimension
Endimension is backed by leaders with immense experience in technology and artificial intelligence. Bharadwaj Kss, Founder & CEO, holds a bachelor’s from IIT Madras and a master’s from IIT Bombay. He has 10 years of experience in Artificial Intelligence & Machine Learning. Apparao Mlv, co-founder & COO, has 10 years of operational and marketing experience. He holds a bachelor’s in technology from ICT Mumbai. Karthik Kannegondla is the Chief Technology Officer and brings 10 years of software development experience to the table along with his B.Tech and M.Tech from IIT Madras.
Ivy Chin, Partner, Inflection Point Ventures says, “The Indian radio-diagnosis market, growing at a CAGR of 15%+ over the last decade, has got a lot of focus on equipment & infrastructure. The under-stated need is that of qualified professionals, i.e. radiologists, to manage this burgeoning demand. There has been growth across tier 1, 2 & 3 for equipment but the availability and prohibitive costs of trained radiologists exacerbates the problem of demand outstripping supply situation. Endimension focuses on leveraging AI to facilitate faster assessment and diagnosis, employing generative AI to streamline report generation and reduce the time required by radiologists. IPV is confident that this investment will contribute towards the betterment of the industry”.
The global market for AI in medical imaging is expected to grow significantly in the coming years. In 2024, the market size is estimated to be around USD 5.86 billion and is projected to reach USD 20.40 billion by 2029, with a compound annual growth rate (CAGR) of 28.32% (Ref: Mordor Intelli). This growth is driven by the increasing demand for early and accurate diagnosis, the rising awareness about chronic diseases requiring imaging services, and the growing adoption of AI technologies in healthcare. Capitalizing on this, Endimension has established itself as an end-to-end AI platform for radiology diagnosis, distinguished by its seamless integration, multiple customization options, and ability to diagnose a wide range of conditions with precision, leading to improved patient outcomes. Endimension’s platform has processed over 1 million scans to date and is currently deployed in 400 hospitals and diagnostic centres across multiple regions, enhancing their accessibility.
Endimension has added several feathers to its cap over the years. The startup was one of the 20 startups selected by Google for Startup Accelerator Class 8 and one of the top 10 startups at the WhatsApp Incubator Programme. They received the Life Science Award at Asian Entrepreneurship Awards. They were winners at SIDBI Investors Day event and have also won the NASSCOM Healthcare Innovation Challenge. Endimension has also been supported and recognised by the Department of Biotechnology, Government of India.
About Endimension Technology
Endimension Technology is a pioneering technology company specializing in AI-driven solutions for radiology diagnostics. Their end-to-end AI platform enhances radiologist efficiency and accuracy by streamlining diagnostic processes and improving detection rates. With over 1 million patient scans processed and deployment in 400+ hospitals and diagnostic centres worldwide, Endimension is at the forefront of revolutionizing radiology and improving global healthcare standards.
About Inflection Point Ventures and Physis Capital
Inflection Point Ventures (IPV) is an angel investing platform with over 14,000+ CXOs, HNIs, and Professionals to together invest in startups. The firm supports new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a diverse group of investors. IPV has announced the launch of a $50 million CAT 2 AIF, Physis Capital, to invest in pre-Series A to Series B growth-stage start-ups.
